Table 1 Descriptive demographic, headache and clinical data of control subjects and MOH patients
|  | Control subjects (n = 16) | Triptans group (n = 18) | NSAIDs group (n = 11) | Mixtures group (n = 14) | Total patients (n = 43) |
|---|---|---|---|---|---|
Age (years) | 46.2 ± 5.4* | 45.7 ± 10.8* | 49.8 ± 7.9 | 56.7 ± 11.8 | 48.4 ± 10.5 |
Gender (F/M) | 12/4 | 16/2 | 11/0 | 13/1 | 40/3 |
BMI | 26.0 ± 3.5 | 25.3 ± 4.4 | 23.4 ± 4.4 | 25.9 ± 6.4 | 25.1 ± 5.0 |
DDI | NA | 1.2 ± 0.4 | 1.9 ± 1.4 | 1.6 ± 0.9 | 1.5 ± 0.9 |
MOH duration (years) | NA | 7.5 ± 5.8 | 8.6 ± 7.9 | 9.0 ± 9.6 | 8.5 ± 7.6 |
LDQ | 14.3 ± 4.2 | 15.7 ± 4.5 | 14.3 ± 6.1 | 17.2 ± 4.2 | 15.5 ± 4.8 |
SBP (mmHg) | 116.4 ± 12.7 | 116.7 ± 15.2 | 110 ± 10.1 | 119.2 ± 16.3 | 115.7±14.1 |
DBP (mmHg) | 70.2 ± 8.5 | 71.1 ± 11.7 | 70.0 ± 10.1 | 71.7 ± 11.7 | 71.0 ± 10.7 |
Serum creatinine (mg/dL) | 0.6 ± 0.2 | 0.8 ± 0.1 | 0.7 ± 0.1 | 0.7 ± 0.2 | 0.7 ± 0.1 |
Serum uric acid (mg/dL) | 4.0 ± 1.1 | 3.8 ± 0.9 | 3.6 ± 1.3 | 4.3 ± 1.6 | 3.9 ± 1.2 |
Urinary pH | 5.3 ± 0.7 | 5.7 ± 0.8 | 5.5 ± 0.7 | 6.2 ± 1.1 | 5.7 ± 0.9 |
Urine specific gravity | 1013 ± 5 | 1018 ± 6 | 1014 ± 6 | 1012 ± 5 | 1015 ± 6 |